Ledger.Open graph →
SEC Form D · filed January 13, 2017

Tarsa Therapeutics, Inc

Offering
$1.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

James Tananbaum · Philadelphia, PADirectorRichard Levy · CHICAGO, ILDirectorRichard Kollender · Philadelphia, PADirectorMartin Edwards · Philadelphia, PADirectorEric Bednarski · Boston, MADirectorLewis Geffen · Boston, MAExecGregory Lumpkin · Philadelphia, PAExecDavid Brand · Boston, MAExec · DirectorRichard Kollender · Philadelphia, PADirectorMartin Edwards · Philadelphia, PADirectorEric Bednarski · Waltham, MADirectorJames Tananbaum · Fort Washington, PADirectorLewis Geffen · BOSTON, MAExecGregory Lumpkin · Philadelphia, PAExecRichard Levy · Lone Tree, CODirectorDavid Brand · Philadelphia, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗